Global Market Study on Adult Hemoglobinopathy Testing: HPLC Test Type to Lead in Terms of Market Share Through 2026


Adult Hemoglobinopathy Testing  Market
  • Published On : Aug-2018 |
  • Pages : 217 Pages |
  • Format :

This Persistence Market Research (PMR) report examines the ‘Global Adult Hemoglobinopathy Testing Market’ for the period 2018–2026. The primary objective of the report is to offer updates and information related to market opportunities in the global adult hemoglobinopathy testing market.

The Adult Hemoglobinopathy Testing Market is Segmented Based on:

  • Variant Type
  • Test Type
  • End Users
  • Region

This report covers the global adult hemoglobinopathy testing market performance in terms of revenue contribution from various segments. The global adult hemoglobinopathy testing market report begins with an overview and definitions. The market viewpoints section underlines macro-economic factors influencing the growth of the global adult hemoglobinopathy testing market along with detailed opportunity analysis of the market. This is then followed by the key drivers, restraints and trends of the global adult hemoglobinopathy testing market.

The global adult hemoglobinopathy testing market is segmented based on variant type, test type, end users and regions. Based on variant type, the global adult hemoglobinopathy testing market is segmented into variant A2 and variant F. Based on test type, the global adult hemoglobinopathy testing market is segmented into HPLC Test, mass spectrometry and Hb electrophoresis. Based on end users, the global adult hemoglobinopathy testing market is segmented into hospitals, reference laboratories and academic & medical institutes. Geographically, the global adult hemoglobinopathy testing market is segmented into North America (the U.S. & Canada), Latin America (Brazil, Mexico, and Rest of Latin America), Europe (Germany, France, the U.K., Italy, Spain and Rest of Europe), Asia Pacific excluding Japan (China, India, Australia & New Zealand and Rest of Asia Pacific), Japan and Middle-East and Africa (GCC Countries, South Africa and Rest of MEA).

A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractive index. The forecast of the adult hemoglobinopathy testing market by country, variant type, test type and end users is represented in a tabular form for each region. This section will help to understand the present scenario and opportunities of the adult hemoglobinopathy testing market in major countries by each segment.

In the next section of the report, the ‘Competitive Landscape’ is included to provide report audiences with a dashboard view of the key competitor firms in order to access the key differentiators among the competitor firms. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to a market segment. The detailed profiles of players operating in the adult hemoglobinopathy testing market are also provided in the report, which highlight company description, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.

The next section of the report highlights the market outlook for 2018–2026 and sets the forecast within the context of the adult hemoglobinopathy testing market by region. A detailed analysis has been provided for each region in terms of market size, Y-o-Y growth rate, absolute $ opportunity, and market attractive index.

The above sections – by variant type, test type and end users – evaluate the historic market analysis and growth prospects of the adult hemoglobinopathy testing market for the period 2018–2026. We have considered 2017 as the base year and provided data for the forecast period.

The final section of the report represents the global scenario of the adult hemoglobinopathy testing market along with y-o-y growth and market forecast till 2026. This section also evaluates the global market opportunity over the forecast period as well as the absolute dollar opportunity for each year. This section will help to understand the overall growth of the adult hemoglobinopathy testing market and the opportunity analysis for every year over the forecast period.

To arrive at the market size, bottom-up approach is used to validate the total market size obtained for the adult hemoglobinopathy testing market. The forecast presented in the report provides total revenue of the adult hemoglobinopathy testing market over 2018–2026. PMR has used a triangulation methodology that is primarily based on experimental techniques, such as patient-level data to obtain precise market estimations for adult hemoglobinopathy testing market and insights on specific country/regions. The country-specific data is again analyzed to derive data at a regional level and then at the global level. This methodology ensures high quality and accuracy of information.

The factors considered while developing the estimates of the adult hemoglobinopathy testing market are disease epidemiology, treatment seeking rate, ratio of population prescribed with different level of testing from complete blood count test to genetic and molecular testing for hemoglobinopathy.

The average selling price (US$) is derived by using weighted average pricing methodology.

On the other hand, PMR has also analyzed the market by considering the revenue from the key players operating a segment. The key players are segmented at the tier level with respect to their revenue, product portfolio and geographical presence. This process involves analysis of various annual reports of companies, investor presentations, SEC filings, 10k reports, earning call transcripts and press releases. This task is done to fetch substantial information about the key players, their respective revenues and estimate their respective market share.

Revenue growth of the key market players is analyzed over the historical period and qualitative assessment of new product launches and innovations has been made in order to validate and align the resultant market numbers. The market structure is closely studied and analyzed at the regional level to map and ascertain incremental $ opportunity for companies, for instance, supply from domestic/regional players, small-scale enterprises or unorganized segments is also taken into consideration to arrive at the final market numbers.

While forecasting the size of the adult hemoglobinopathy testing market, we have considered the impact of several factors such as per capital healthcare expenditure, disposable income, new testing methods and approvals for new rapid POC tests, penetration of adult hemoglobinopathy testing through various end users, generic penetration across all regions, etc. However, quantifying the market across the aforementioned segments and regions is more a matter of quantifying expectations and identifying opportunities rather than rationalizing them after the forecast has been completed. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

Market Value and Forecast

The global adult hemoglobinopathy testing market is projected to grow at a CAGR of 3.9% throughout the forecast period (2018–2026).

Adult Hemoglobinopathy Testing Market: Key Insights

  • Favorable reimbursement for adult hemoglobinopathy testing is expected to drive the growth of the adult hemoglobinopathy testing market over the forecast period.
  • Offering of prenatal testing and use of advanced molecular testing are expected create lucrative opportunities for the new players entering the adult hemoglobinopathy testing market.
  • Development of various rapid POC diagnostic methods for sickle cell disorder and thalassemia is expected to spur the growth of the market for adult hemoglobinopathy testing over the forecast period.
  • Europe, followed by Asia Pacific excluding Japan, is expected to be the leading market for adult hemoglobinopathy testing, owing to growing immigration from high-risk regions
  • The increase in number of cases of hemoglobinopathy in Northern and Central Europe, particularly in Germany, owing to immigration is expected to drive the growth of the market for adult hemoglobinopathy testing over the forecast period.
  • Around 15 million people across the globe suffer from thalassemia disorders and nearly 1.5% of the world population is estimated to be carrier of β-thalassemia, which are the other factors expected to drive the growth of the global market for adult hemoglobinopathy testing over the forecast period.
  • Asia-Pacific adult hemoglobinopathy testing market is projected to have continuous growth over the forecast period due to increasing prevalence of hemoglobinopathy in various ethnic groups.
  • Robust research and development related to hemoglobinopathy testing have given rise to development of various new diagnostic techniques such as cation-exchange HPLC, point-of-care lateral flow immunoassay, colorimetric quantification of PCR-amplified DNA, molecular identification of alpha and beta chain mutation analyses and HPLC tandem mass for identification of hemoglobin variants, which are expected to create numerous opportunities in adult hemoglobinopathy testing market.
  • Premarital and prenatal genetic testing for the sickle cell trait identification is rapidly gaining popularity in developed as well as developing countries, which is projected to spur the growth of the adult hemoglobinopathy testing market over the forecast period.
  • Over the last decade, the leading companies operating in the adult hemoglobinopathy testing market are focusing on advanced diagnostics and therapeutics for adult hemoglobinopathy testing.
  • Various supportive initiatives are been taken from the government and non-government organizations in low- and middle-income countries, which support people in collaboration with private donations
  • A number of regional, national and international non-government organizations are actively involved in increasing the awareness regarding various hemoglobinopathy conditions. These NGOs provide financial aid to patients who cannot afford the diagnosis and treatment costs
  • Reduction in the overall cost of testing and various government screening programs are expected to create attractive revenue share for the key players operating in the adult hemoglobinopathy testing market
  • Lower cost of Hb test & high prevalence of hemoglobinopathy in Asia & Africa are the factors expected to drive the market growth

Factors and Trends Impacting the Growth of the Adult Hemoglobinopathy Testing Market

Hemoglobinopathy is one of the most common hereditary diseases worldwide. Hemoglobinopathy encompasses genetic disease of hemoglobin, which falls mainly into two groups, i.e., thalassemia and structural hemoglobin variants. Hemoglobinopathy disorder is caused by the presence of variant hemoglobin in the red blood cells. The adult hemoglobinopathy testing market is segmented on the basis of variant type, test type, end users and region. On the basis of test type, the HPLC test segment in adult hemoglobinopathy testing market is expected to account a large revenue share over the forecast period owing to its accuracy and use of HPLC as compared to other segment test types. However, lack of awareness regarding hemoglobinopathy testing and disorders among the general population, especially in underdeveloped and developing economies, high prevalence of the disease, highly complex tests for hemoglobinopathy, and lack of access to screening procedures with various accurate technologies, such as genetic testing, are some of the prime factors expected to hamper the growth of the adult hemoglobinopathy testing market over the forecast period.

Adult Hemoglobinopathy Testing Market: Regional Outlook

The global adult hemoglobinopathy testing market is segmented into six key regions, namely North America, Latin America, Europe, and Asia Pacific excluding Japan, Japan, and the Middle East & Africa. In terms of value, Europe is a large regional market for adult hemoglobinopathy testing and is expected to have significant growth during the forecast period. The Asia Pacific excluding Japan adult hemoglobinopathy testing market is projected exhibit significant growth over the forecast period due to increasing prevalence of hemoglobinopathy in the region, particularly in China and India.

adult-hemoglobinopathy-testing-market.jpg

Adult Hemoglobinopathy Testing Market: Key Players

Examples of some of the key players operating in the global adult hemoglobinopathy testing market are Trinity Biotech, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., PerkinElmer Inc., Chromsystems Instruments & Chemicals GmbH, BioMedomics, Inc, CapitalBio Technology Inc, and Streck, Inc., among others

Company Profiles

  • Bio-Rad Laboratories, Inc.
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • Chromsystems Instruments & Chemicals GmbH
  • BioMedomics, Inc
  • CapitalBio Technology Inc
  • Overview
  • Trinity Biotech
  • Streck, Inc .
  • Others.
Back To Top